Withdrawn study sought to see inside tumors before treatment
NCT ID NCT06922825
Summary
This pilot study aimed to test a new imaging method to see if it could help predict how well patients with solid tumors respond to antibody-based therapies. Participants would have received a special imaging tracer and a PET/CT scan before starting their standard treatment. The goal was to see if the scan results correlated with how well the treatment worked over the following three years, but the study was withdrawn before any participants were enrolled.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States
Conditions
Explore the condition pages connected to this study.